Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AORT | Common Stock | Options Exercise | $671K | +65.5K | +13.2% | $10.24 | 562K | Feb 14, 2023 | Direct | F1 |
transaction | AORT | Common Stock | Sale | -$747K | -56.5K | -10.05% | $13.22 | 506K | Feb 14, 2023 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AORT | Stock Options (Right to buy) | Options Exercise | -$671K | -65.5K | -100% | $10.24 | 0 | Feb 14, 2023 | Commn Stock | 65.5K | $10.24 | Direct | F3 |
Id | Content |
---|---|
F1 | The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 14, 2022 |
F2 | Reflects the price of $ 13.224856 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price |
F3 | Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2017. |